Clinical evaluation of teicoplanin fluorescence polarization immunoassay. - Wikidata - wikimedia - TriplyDB

Clinical evaluation of teicoplanin fluorescence polarization immunoassay.

Clinical evaluation of teicoplanin fluorescence polarization immunoassay.

http://www.wikidata.org/entity/Q40087066

about

Bactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of endocarditis.Bactericidal activities of two daptomycin regimens against clinical strains of glycopeptide intermediate-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecium, and methicillin-resistant Staphylococcus aureus isolates in an in vi Therapeutic drug monitoring of antimicrobials.Absence of "red man syndrome" in patients being treated with vancomycin or high-dose teicoplanin.Efficacy of linezolid against methicillin-resistant or vancomycin-insensitive Staphylococcus aureus in a model of hematogenous pulmonary infection.Teicoplanin and daptomycin bactericidal activities in the presence of albumin or serum under controlled conditions of pH and ionized calcium Evaluation of a novel fluorescence polarization immunoassay for teicoplanin Effects of DQ-113, a new quinolone, against methicillin- and vancomycin-resistant Staphylococcus aureus-caused hematogenous pulmonary infections in mice.Analysis using fluorescence polarization immunoassay for unbound teicoplanin concentration in serum.Nephrotoxicity of concomitant use of tacrolimus and teicoplanin in allogeneic hematopoietic stem cell transplant recipients.

P2860

Q33758399-B0C7A0C2-5CBA-4189-881A-94992AAEFA3D Q33981366-A4A452E5-18EB-48E7-A08D-0483A6904740 Q35640430-33B31C67-852F-48E6-9C6D-87113577DE07 Q35862551-DFE2C145-7A41-44F0-9754-B6D1BFDAD142 Q39658141-88BCB062-28B9-4085-A005-C401D564D298 Q39865308-AC91A3B3-44B9-4FB8-A410-0D6D44DDD3C3 Q39866638-A48078EC-C85E-4EEE-B370-0EC0F5A53D04 Q40345393-53DAEF67-F70C-4538-A7B0-48EBBBA67D36 Q46493358-190D3E9D-2DB3-456C-ADF7-7ABCF2400F29 Q53068120-2E199C7A-DFD8-4BCF-B903-025ED0BC836D

P2860

Clinical evaluation of teicoplanin fluorescence polarization immunoassay.

http://www.wikidata.org/entity/Q40087066

description

1991 nî lūn-bûn

@nan

1991年の論文

@ja

1991年論文

@yue

1991年論文

@zh-hant

1991年論文

@zh-hk

1991年論文

@zh-mo

1991年論文

@zh-tw

1991年论文

@wuu

1991年论文

@zh

1991年论文

@zh-cn

name

Clinical evaluation of teicoplanin fluorescence polarization immunoassay.

@en

type

label

Clinical evaluation of teicoplanin fluorescence polarization immunoassay.

@en

prefLabel

Clinical evaluation of teicoplanin fluorescence polarization immunoassay.

@en

P1433

Q40087066-F01D530B-1BED-4F94-A9B1-D35C11B114C3

P1476

Q40087066-94ED3A13-2D37-416E-9B25-66F976C158E5

P2093

Q40087066-42FDA056-7862-439D-86BA-0CB9EC12D38C

Q40087066-4C4BC56B-BE68-4792-B133-74816086F285

Q40087066-F8468573-CA54-4FC9-AEB5-6FB59BEB71F0

P2860

Q40087066-06C188D4-F931-41FC-B0D9-D631214310CE

Q40087066-67D6529D-817B-48EA-94DC-78EC0CF38024

Q40087066-A4F2F8D1-3DA8-4BEA-AE58-A644544D5866

Q40087066-BB4D76A2-FE00-4EA3-90FD-E3D5D61C1BCB

Q40087066-BC75743C-EF27-444E-B4DB-C22310E99129

Q40087066-C0E7711B-D98B-4111-89DB-A7936AA0B7F7

Q40087066-CAFE47F6-B96A-4B21-A075-511EAF1CCF9E

Q40087066-D06C1885-B066-4EE2-A854-9EEFC03F6740

Q40087066-E28BBBCD-6346-4F68-B8F6-7502DCD3B052

Q40087066-FFA8A8E4-D45B-456B-884A-7B2BE3DE98BD

P304

Q40087066-C9FAFFBC-356D-4667-8F10-BCEC724A210C

P31

Q40087066-211D2A5A-B007-4AC5-B213-615D101D1CEE

P356

Q40087066-2CCD509D-0031-4F8F-8CDB-0D7D63D3C958

P407

Q40087066-379D33EC-2AE4-4951-BC5B-D9A2E82ADA20

P433

Q40087066-69D5FDCD-99F9-47BD-9618-A4F1C6C67083

P478

Q40087066-6FEA795C-8321-4E2D-BDE8-A4992108F9F9

P577

Q40087066-818997DB-98FE-45A4-A149-EA02899A02CB

P698

Q40087066-15ADD6F9-36C2-4C1F-B7E8-D370455E68C9

P932

Q40087066-01AEC1D7-22CA-42EC-BADF-0BAFCC7097BC

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Clinical evaluation of teicoplanin fluorescence polarization immunoassay.

@en

P2093

Bailey EM

http://www.w3.org/2001/XMLSchema#string

Reddy VN

http://www.w3.org/2001/XMLSchema#string

Rybak MJ

http://www.w3.org/2001/XMLSchema#string

P2860

Teicoplanin pharmacokinetics in intravenous drug abusers being treated for bacterial endocarditis

Effects of dosage, peak and trough concentrations in serum, protein binding, and bactericidal rate on efficacy of teicoplanin in a rabbit model of endocarditis.

Clinical evaluation of efficacy, pharmacokinetics, and safety of teicoplanin for serious gram-positive infections.

Clinical evaluation of teicoplanin for therapy of severe infections caused by gram-positive bacteria.

Failure of treatment with teicoplanin at 6 milligrams/kilogram/day in patients with Staphylococcus aureus intravascular infection. The Infectious Diseases Consortium of Oregon.

Determination of teicoplanin concentrations in serum by high-pressure liquid chromatography.

In vitro activity and human pharmacokinetics of teicoplanin.

Teicoplanin in the treatment of infection caused by gram-positive organisms.

A sensitive bioassay for teicoplanin in serum in the presence or absence of other antibiotics.

Bioassay of teicoplanin in serum containing rifampin or a beta-lactam antibiotic.

P304

1586-1590

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.35.8.1586

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P577

1991-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

1834014

http://www.w3.org/2001/XMLSchema#string

P932

245223

http://www.w3.org/2001/XMLSchema#string